OPEN END TURBO CALL-OPTIONSSCHEIN MIT SL - ELI LILLY & CO | Market Closed - Bid/Ask 19:48:29 10/05/2024 BST | After market 20:47:36 | |||
| 59.65 EUR | -1.63% |
|
59.54 | -0.19% |
| Current month | -2.00% | ||
| 1 month | +0.95% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/05/24 | 59.65 | -1.63% | 0 |
| 09/05/24 | 60.64 | -0.85% | 0 |
| 08/05/24 | 61.16 | -0.05% | 0 |
| 07/05/24 | 61.19 | +6.90% | 0 |
| 06/05/24 | 57.24 | -0.19% | 80 |
Delayed Quote Börse Stuttgart
Last update May 10, 2024 at 07:48 pm
More quotesStatic data
| Product type | Knock-Out mit Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
Société Générale
|
| WKN | CJ5RRG |
| ISIN | DE000CJ5RRG0 |
| Date issued | 07/11/2018 |
| Strike | 119.1 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.76 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 62.5 € |
|---|---|
| Lowest since issue | 0.86 € |
| Spread | 0.07 € |
| Spread % | 0.12% |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
771.6
USD
Average target price
850.4
USD
Spread / Average Target
+10.22%
- Stock Market
- Certificates
- Certificat
